These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Absence epilepsies with widely variable onset are a key feature of familial GLUT1 deficiency. Mullen SA; Suls A; De Jonghe P; Berkovic SF; Scheffer IE Neurology; 2010 Aug; 75(5):432-40. PubMed ID: 20574033 [TBL] [Abstract][Full Text] [Related]
31. Three novel SLC2A1 mutations in Bulgarian patients with different forms of genetic generalized epilepsy reflecting the clinical and genetic diversity of GLUT1-deficiency syndrome. Ivanova N; Peycheva V; Kamenarova K; Kancheva D; Tsekova I; Aleksandrova I; Hristova D; Litvinenko I; Todorova D; Sarailieva G; Dimova P; Tomov V; Bozhinova V; Mitev V; Kaneva R; Jordanova A Seizure; 2018 Jan; 54():41-44. PubMed ID: 29223885 [TBL] [Abstract][Full Text] [Related]
32. Glut1 deficiency: when to suspect and how to diagnose? Verrotti A; D'Egidio C; Agostinelli S; Gobbi G Eur J Paediatr Neurol; 2012 Jan; 16(1):3-9. PubMed ID: 21962875 [TBL] [Abstract][Full Text] [Related]
33. The role of molecular analysis of SLC2A1 in the diagnostic workup of glucose transporter 1 deficiency syndrome. Takahashi S; Tanaka R; Takeguchi R; Kuroda M; Akaba Y; Ito Y J Neurol Sci; 2020 Sep; 416():117041. PubMed ID: 32712428 [TBL] [Abstract][Full Text] [Related]
34. Glucose transporter 1 deficiency as a treatable cause of myoclonic astatic epilepsy. Mullen SA; Marini C; Suls A; Mei D; Della Giustina E; Buti D; Arsov T; Damiano J; Lawrence K; De Jonghe P; Berkovic SF; Scheffer IE; Guerrini R Arch Neurol; 2011 Sep; 68(9):1152-5. PubMed ID: 21555602 [TBL] [Abstract][Full Text] [Related]
35. The clinical and biochemical hallmarks generally associated with GLUT1DS may be caused by defects in genes other than SLC2A1. Sánchez-Lijarcio O; Yubero D; Leal F; Couce ML; González Gutiérrez-Solana L; López-Laso E; García-Cazorla À; Pías-Peleteiro L; de Azua Brea B; Ibáñez-Micó S; Mateo-Martínez G; Troncoso-Schifferli M; Witting-Enriquez S; Ugarte M; Artuch R; Pérez B Clin Genet; 2022 Jul; 102(1):40-55. PubMed ID: 35388452 [TBL] [Abstract][Full Text] [Related]
36. Glucose transporter-1 (GLUT1) deficiency syndrome: diagnosis and treatment in late childhood. Gramer G; Wolf NI; Vater D; Bast T; Santer R; Kamsteeg EJ; Wevers RA; Ebinger F Neuropediatrics; 2012 Jun; 43(3):168-71. PubMed ID: 22622956 [TBL] [Abstract][Full Text] [Related]
37. Differentiating non-epileptic seizures from epileptic seizures in Glut1 deficiency syndrome. Ito Y; Nakatsukasa H; Toyoma Y; Nagata S; Oguni H Dev Med Child Neurol; 2024 Nov; 66(11):1466-1475. PubMed ID: 38655597 [TBL] [Abstract][Full Text] [Related]
38. Video/EEG recording of myoclonic absences in GLUT1 deficiency syndrome with a hot-spot R126C mutation in the SLC2A1 gene. Gökben S; Yılmaz S; Klepper J; Serdaroğlu G; Tekgül H Epilepsy Behav; 2011 Jun; 21(2):200-2. PubMed ID: 21546317 [TBL] [Abstract][Full Text] [Related]
39. New Paradigm for the Treatment of Glucose Transporter 1 Deficiency Syndrome: Low Glycemic Index Diet and Modified High Amylopectin Cornstarch. Almuqbil M; Go C; Nagy LL; Pai N; Mamak E; Mercimek-Mahmutoglu S Pediatr Neurol; 2015 Sep; 53(3):243-6. PubMed ID: 26216499 [TBL] [Abstract][Full Text] [Related]
40. A Different SLC2A1 Gene Mutation in Glut 1 Deficiency Syndrome: c.734A>C. Çolak R; Alkan Özdemir S; Yangın Ergon E; Kağnıcı M; Çalkavur Ş Balkan Med J; 2017 Dec; 34(6):580-583. PubMed ID: 28443597 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]